Explore more Articles in

Stock Sectors

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness...

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year,...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities,...
Energy Stocks

WTI Prices Jump Even as Middle East Keeps Oil Flowing Uninterrupted

Oil prices have fluctuated due to concerns about potential supply disruptions in the Middle East following recent Israeli strikes on Iran, but no actual...
BioTech

Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday? – Aptevo Therapeutics (NASDAQ:APVO)

Aptevo Therapeutics Inc APVO stock is surging on Wednesday.As per data from Benzinga Pro, the stock is trading higher with a strong volume of...
Energy Stocks

The Energy Report: Ayatollah’s Last Stand

Out of the bunker we have heard from Iran’s Supreme Leader and Grand Poobah Ayatollah Ali Khamani saying that, “The United States should know...
BioTech

EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria – Telomir Pharmaceuticals (NASDAQ:TELO)

Telomir Pharmaceuticals Inc. TELO on Wednesday announced new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines...
BioTech

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study – Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)

When it comes to type 1 diabetes, treating this chronic condition can be difficult. After all, with this type of diabetes, the body's immune...
Energy Stocks

Oil Rally May Extend as US Weighs Deeper Involvement in Iran-Israel Conflict

Energy markets continue to monitor escalating Israel-Iran conflict, focusing on any signs that Iran may seek to disrupt flows across the Strait of...
1...232425...29Page 24 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.